FindTrial
Sign In

Comparing treatments for gum disease with clindamycin gel and standard cleaning

Comparative evaluation of effectiveness of 1 percent Clindamycin gel with Phase 1 therapy in the treatment of Stage II Periodontits A Randomized Controlled Trail - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/105349
Enrollment
26
Registered
2026-03-05
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K053- Chronic periodontitis

Interventions

Intervention1: 1% Clindamycin gel: 1% Clindamycin gel will be given once as local drug delivery after scaling and root planing Dose : 1 percent local drug delivery gel frequency : once after scaling a

Sponsors

Dr Sarumathi S
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients willing for voluntary participation & have signed informed consent 2. Patients within the age group 20 - 45 years of either gender 3. Free from systemic diseases that might influence the periodontal conditions 4. Patients with stage II periodontitis 5. Patients with probing depth of 3-5mm . 6. Patients who have not received any treatment or medications for the past 6 months.

Exclusion criteria

Exclusion criteria: 1. Patients using any form of tobacco 2. Pregnant or lactating women 3. Patients with known allergies to Clindamycin 4. Patients who are alcoholics 5. Patients who have received any known surgical or non- surgical periodontal treatment within 6months of the start of the study 6. Patients who had taken antibiotics, chemotherapeutic mouth rinses within the last 6 months of the start of the study. 7. Patient with known systemic diseases that might influence the periodontal condition.

Design outcomes

Primary

MeasureTime frame
1. Plaque index (Silness and Loe, 1964) (PI) 2. Gingival Bleeding index (Animo and Bay, 1975) (GBI) 3. Probing Pocket Depth (using UNC 15 probe with customized acrylic stents) (PPD) 4. Clinical Attachment Level (measured using the customized acrylic stents) (CAL) all the outcome will be assessed at baseline and 2 months after interventionTimepoint: 1. Plaque index (Silness and Loe, 1964) (PI) 2. Gingival Bleeding index (Animo and Bay, 1975) (GBI) 3. Probing Pocket Depth (using UNC 15 probe with customized acrylic stents) (PPD) 4. Clinical Attachment Level (measured using the customized acrylic stents) (CAL) all the outcome will be assessed at baseline and 2 months after intervention—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Muthukumaraswamy

Tamilnadu Government Dental College and Hospital, Chennai

malsmoni@gmail.com9444040620

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026